Shape Therapeutics
PrivateLast Round
Series B
Jul 15, 2021
Total Funding Raised
$147.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Shape Therapeutics is a biotechnology company that develops programmable RNA medicines to address genetic diseases using AI-driven RNA editing and gene therapy platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shape Therapeutics Comparables
Compare Shape Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRNA | 87% | |
| Ascidian Therapeutics | 84% | |
| Amber | 82% |
Shape Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 15, 2021 | ||||
| Series A | Nov 5, 2019 |
Key People
Founding team and executive leadership
Shape Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | Series A |
| New Enterprise Associates | Series B, Series A |
| BioInnovation Capital | Series B |
| Mission BioCapital | Series B |
| Willett Advisors | Series B |
| Decheng Capital | Series B |
| Breton Capital Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 62% MoM, reaching 4.6K.
- Dec 16, 2025
Collaborating with VectorY Therapeutics on vectorized antibody therapies for neurodegenerative diseases.
Shape Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shape Therapeutics's valuation, stock price, and market status.
Is Shape Therapeutics a public or private company?
Shape Therapeutics is a private company.
What is the current stock price of Shape Therapeutics?
Shape Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Shape Therapeutics worth (valuation)?
Valuation information for Shape Therapeutics is not publicly available.
Can I buy Shape Therapeutics stock?
Shape Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shape Therapeutics's last funding round?
Shape Therapeutics's most recent funding round was Series B on July 15, 2021.
Who are the main investors in Shape Therapeutics?
Key investors in Shape Therapeutics include New Enterprise Associates (NEA), Decheng Capital, Breton Capital Ventures.
Will Shape Therapeutics IPO soon?
No public IPO plans have been announced for Shape Therapeutics.
How can I track Shape Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shape Therapeutics's secondary market activity and sign up for updates.